Saturday, July 23, 2016

This Is My Second Letter To You!!

This Is My Second Letter To You.

I am contacting you again because you bear the surname credentials of a deceased client and therefore can present you as the beneficiary to the inheritance in the intent of the deceased since there is no written will "intestate" Our legal services aim to provide our private clients with a complete service; we are ready to prepare files, set-up and administer Trusts, carry out the Administration Of Estates, prepare and administer Powers of Attorney.

All papers will be processed in your acceptance. In your acceptance of this deal, kindly forward your letter of acceptance, your current telephone and fax numbers and a forwarding address to to enable us file necessary documents at our High Court Probate division for the release of this sum of money in your favor.

Warm regards,


Sunday, July 3, 2016

Abstract for Talk on Genomic Privacy at Birkbeck College in July 2016

Genomic Privacy

I will talk about Genomic Privacy in general and then in relation to a
specific application of RNA-seq data. In general, with every new
exciting development in genomics come the often
under-appreciated ethical, legal and social concerns. Particularly with
regard to issues of privacy, there are tradeoffs as the
technology continues to develop and the real-life applications of
genomics become more of a reality. Numerous technical solutions have
been proposed, but every technical safeguard is accompanied by
increased complications with analyzing and manipulating datasets.
Moreover, technical solutions invite both white-hat and black-hat
efforts of circumvention, making them less useful in the long-run.
I propose a multi-prong approach to dealing with privacy
issues in genomics that includes technical, regulatory and social
advances that will create an environment that both safeguards privacy,
prevents harms associated with a lack of privacy and promotes
innovation in the fields of genomics and medicine.

To illustrate the complex aspects of privacy, I go through two case
studies that inter-relate RNA-seq data (and functional genomics data,
in general) with variants. On one hand, scientists can use these data
to generate general conclusions; on the other hand it is interesting
and worthwhile to relate it to genetic variants. I go over some
aspects of private information leakage in dealing with RNA-seq,
particularly related to eQTLs. Then I describe aspects of RNA-seq
calculations that cannot be abstracted from variants -- particularly,
those related to allele-specific expression.